Perioperative Morbidity of Secondary Frontal Orbital Advancement After Initial Frontal Orbital Advancement

J Craniofac Surg. 2023 Jan-Feb;34(1):173-176. doi: 10.1097/SCS.0000000000009002. Epub 2022 Sep 8.

Abstract

Frontal orbital advancement (FOA) is frequently performed for patients with syndromic and/or multisuture craniosynostosis. A small proportion of patients who undergo FOA have unfavorable growth and subsequently require a second FOA later in life; however, the perioperative risks associated with this second procedure are not well studied. We report results from a retrospective review of FOAs conducted from 2007 to 2022 at a single site with the same craniofacial surgeon. A total of 33 patients were included. Perioperative outcomes were compared between primary and secondary FOA procedures. The two groups were similar in regard to suture involvement and diagnosis, although the secondary FOA group was older at the time of their FOA (1.23 versus 7.07 y, P <0.001). There was no significant difference between groups in operating time, volume of blood transfusion by weight, or in the incidence of postoperative wound complications ( P >0.05). Primary FOA procedures had significantly higher weight-adjusted blood loss (28 versus 18 mL/kg, P =0.014), with a higher proportion of patients receiving a blood transfusion (95% versus 62%, P =0.025). There was no significant difference between groups in the incidence of intraoperative dural injury (50% versus 84%, P =0.067). Our findings suggest that secondary procedures appear to impose less of a surgical risk relative to primary FOA traditionally performed in infancy, likely because of the advanced age at the time of secondary FOA.

MeSH terms

  • Blood Transfusion
  • Craniosynostoses* / complications
  • Craniosynostoses* / surgery
  • Humans
  • Infant
  • Morbidity
  • Neurosurgical Procedures / adverse effects
  • Postoperative Complications / etiology
  • Retrospective Studies